伊卡林通过抑制神经细胞的铁亡来改善认知障碍
Yang Yang1, Yiming Fu2, Zhipeng Qin2
1Shenyang Medical College, Shenyang 110000, Liaoning Province, China.
Aging
|October 27, 2023
概括
伊卡里因 (ICA) 通过抑制铁亡,改善了阿尔茨海默病 (AD) 的小鼠的神经行为和认知功能. 这种神经保护作用通过MDM2途径进行介导,为AD提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降.
- 铁亡,一种受调节的细胞死亡形式,以及氧化应激在AD病变发生过程中起着重要作用.
- 伊卡林 (ICA) 是一种具有潜在治疗功能的天然化合物.
研究的目的:
- 在阿尔茨海默病 (AD) 的小鼠模型中研究伊卡林 (ICA) 对神经行为缺陷的治疗作用.
- 阐明ICA作用的潜在机制,重点关注铁和氧化应激.
- 在AD的背景下,识别ICA的潜在分子标.
主要方法:
- 使用了10个月大的APP/PS1转基因小鼠 (AD模型) 和野生型C57BL/6J小鼠 (控制).
- 通过胃内测量给药ICA,并使用莫里斯水迷宫评估神经行为性能.
- 量化了关键的铁亡指标和氧化应激标志物;使用网络药理学来预测ICA目标.
主要成果:
- 在AD小鼠中,Icariin的使用显著改善了神经行为,记忆和运动功能.
- 在AD模型中,ICA治疗降低了ferroptosis水平,并增强了对氧化应激的抵抗力.
- 抑制MDM2消除了ICA对认知能力和铁亡的有益影响,这表明MDM2是关键目标.
结论:
- 伊卡林 (ICA) 在阿尔茨海默病小鼠模型中显示出显著的神经保护作用.
- ICA通过抑制神经细胞中的铁亡来改善神经损伤.
- 该机制涉及准MDM2,突出其作为AD治疗剂的潜力.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:22Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K